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Abstract: Hormonal changes associated with pregnancy promote oral bacterial growth, which
may affect salivary nitric oxide (NO) levels, oxidative stress (OS), and antioxidant capacity (AC).
We hypothesized that caries-related bacterial load, NO level, and OS in the saliva change with
advancing gestation. The aim of this study was to investigate longitudinal changes in salivary NO,
OS, and AC during pregnancy and correlate them with Streptococcus mutans (SM) and Lactobacillus
(LB) colonization at different stages of pregnancy. We assessed NO level by Griess method, OS by
measuring malondialdehyde (MDA), AC by ABTS radicals and bacterial load by culturing SM and
LB in the saliva of pregnant women (n = 96) and compared with non-pregnant women (n = 50) as
well as between different stages of pregnancy. Compared with non-pregnant women, NO was 77%
higher (4.73± 2.87 vs. 2.67± 1.55 µM; p < 0.001), MDA was 13% higher (0.96± 0.27 vs. 0.85± 0.22 nM;
p = 0.0055), and AC was 34% lower (60.35 ± 14.33 vs. 80.82 ± 11.60%; p < 0.001) in the late third
trimester. NO increased with advancing gestation, but AC and OS did not change significantly
during pregnancy. SM were more abundant in pregnant women compared with non-pregnant
(p = 0.0012). Pregnancy appears to have an adverse impact on oral health emphasizing the importance
optimal oral healthcare during pregnancy.
Keywords: antioxidant capacity (AC); Lactobacillus; malondialdehyde (MDA); nitric oxide (NO); oral
health; oxidative stress (OS); pregnancy; saliva; Streptococcus mutans
1. Introduction
Saliva plays a vital role in the digestive tract contributing to the maintenance, preser-
vation, lubrication, protection, and healing of intra-oral hard and soft tissues. Saliva is
widely used as a screening and diagnostic tool because of its simple non-invasive collection
process and the presence of several biomarkers [1–3]. Normal pregnancy is associated
with altered flow, composition, and pH of saliva, which promotes bacterial growth and
predisposes women to poor oral health [4]. Furthermore, physiological endocrine, cardio-
vascular, immunological, and metabolic adaptations of pregnancy may also contribute
to increased colonization of oral cavity by pathogenic microbes leading to inflammatory
response and oxidative stress. Nitric oxide (NO) has a key role in pregnancy as a regu-
lator of both maternal and fetal homeostasis [5], and its levels in the saliva are likely to
reflect local conditions of the oral cavity. However, although there are a limited number of
cross-sectional studies measuring NO levels in maternal serum during pregnancy [6,7], no
study to our knowledge has performed NO measurements in the saliva of pregnant women
longitudinally. Saliva also plays an important role in the immunological and enzymatic
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defense mechanisms against certain microorganisms’ antioxidant systems, and human
body’s oxidative stress (OS) levels are expressed in saliva [8]. A recent systematic review
on maternal oral microflora has reported that the pregnancy is associated with abundance
of micro-organisms compared to non-pregnant state [9]. In a cross-sectional study, we
have previously demonstrated an increased level of OS in the saliva of pregnant women
compared to non-pregnant in association with increased colonization of oral cavity by
dental caries-related pathogen, Streptococcus mutans (SM) [10]. Increased levels of NO and
OS have been measured in the blood samples of pregnant women compared to healthy
non-pregnant women [6,11]. Therefore, longitudinal measurements of NO and OS levels
in the saliva of pregnant women, together with the assessment of pathogenic bacterial load
could help to elucidate the link between OS and oral health during the course of normal
pregnancy. We hypothesized that the colonization by caries-related bacteria, OS level, and
antioxidant capacity (AC) change during pregnancy with advancing gestational age. We
aimed to investigate associations of oral pathogenic bacterial load represented by SM and
Lactobacillus (LB), with salivary NO and OS levels during the progression of pregnancy.
2. Materials and Methods
2.1. Study Design
This single center observational cohort with comparison group was part of a lon-
gitudinal study on oral health in pregnancy conducted at UiT-The Arctic University of
Norway and University Hospital of North Norway, Tromsø, Norway. Saliva samples were
collected consecutively from healthy pregnant women four times during gestation starting
at 18–20 weeks to term. The samples were divided into 4 groups by gestational age; early
second trimester (18–20 weeks), late second trimester (24–26 weeks), early third trimester
(30–32 weeks), and late third trimester (36–40 weeks). The comparison group comprised of
healthy non-pregnant women of reproductive age without history of any chronic illness
or recent disease. These were recruited among women working at the UiT-The Arctic
University of Norway or the University Hospital of North Norway, Tromsø. Pregnant
women were approached and recruited to the study when they attended the hospital for
routine ultrasound screening at 18–20 weeks of gestation. General inclusion criteria were:
(1) age over 18 years, (2) low risk singleton pregnancy, (3) women without any previous
history of pregnancy-associated complications, such as preeclampsia, preterm birth, or
gestational diabetes, and (4) absence of any pre-existing medical condition that may have
an impact on the course and outcome of pregnancy. Those pregnant women who were
unable to communicate in Norwegian or English, and those who have been diagnosed with
a fetal chromosomal or structural anomaly and did not plan to continue their pregnancy,
were excluded. A history of any acute or chronic illness requiring regular medical treatment
excluded participation for the non-pregnant women. Pregnant study participants were
followed from mid-gestation until childbirth, and the outcome of pregnancy was recorded.
All participants were informed about the study in advance and a written consent was
obtained from all the participants. The study was approved by the Regional Committee for
Medical and Health Research Ethics-North Norway (Ref No: 2012/633/REK nord).
2.2. Collection of Samples
For both pregnant and non-pregnant groups, saliva samples were collected during day-
time between 9:00 and 15:00 h with the same method as described previously [10]. Women
were not eating or brushing their teeth for approximately 1.0 to 1.5 h before sampling. In
brief, the participants were asked chew paraffin wax pellets for 5 min to stimulate saliva
production which was then collected by expectorating in sterile disposable cups.
For the assessment of caries related bacterial load in the saliva, SM and LB were
cultured and colony forming units (CFU) were evaluated by a single investigator (MW).
For the measurement of NO and OS levels, 1.8 mL of saliva was collected in two separate
cryo-tube vials and stored at −70 ◦C until samples were analyzed by a single investigator
(PB). Samples were put in a refrigerator at 4 ◦C for one day before the analyses were
Int. J. Environ. Res. Public Health 2021, 18, 9330 3 of 12
performed. All samples were left for 2 h on the working table before the analysis to defrost
and bring to room temperature. Sample containing tubes were centrifuged at 10,000× g
for 10 min to remove cell debris and supernatant was collected for further analysis. Storing-
procedures and laboratory analyses were followed according to the instructions by the
kit supplier.
2.3. Chemicals
All chemical used were of analytical grade. 2,2′-azino bis(3-ethylbenzothiazoline)-6-
sulfonic acid diammonium salt (ABTS), vitamin C (ascorbic acid), acetic acid, and sodium
nitrite were purchased from Sigma-Aldrich, Chemie GmbH, Steinheim, Germany. Potas-
sium peroxodisulphate was a product from Merck KGaA, Darmstadt, Germany. Griess
reagent was prepared from 1% sulfanilamide, 0.1% naphthylethylene diamine dihydrochlo-
ride, and 2.5% phosphoric acid, all products were from Sigma-Aldrich Norway AS, Oslo.
2.4. Measurement of NO Levels
Because NO is highly labile, measurement of the relatively stable metabolite, nitrate
and nitrite (NOx), is employed as an index of NO production and, also, as a marker of
NOS enzyme activity [12]. The levels of NO in saliva were expressed by measuring nitrite
quantitatively using the Griess method spectrophotometrically with modification [13].
Griess reagent was prepared as 1% sulfanilamide and 0.1% N-naphthylethylene diamine
dichloride in 5% orthophosphoric acid (v/v). This reagent reacts with nitrite and produces
a purple azo dye end-product, which is measured spectrophotometrically with a maximum
absorbance at 546 nm. Triplicate samples of saliva (10 µL) were transferred to a tube
containing 290 µL of distilled water, and a 300 µL of Griess reagent was added to each
tube. After mixing thoroughly and allowing to react at dark for 30 min, the changed color
was measured. The quantitative expression of NO in saliva is taken from the analysis
of triplicates of sodium nitrite (NaNO2) at concentrations of 25, 20, 15, 10, 5, 2, 1, and
0 µM as final concentrations and with the help of standard curve and regression equation
(R2 = 0.9995 and y = 0369x − 0.0035). The intra-assay coefficient of variation was 4.89%
2.5. Measurement of Antioxidant Capacity (AC)
Antioxidant capacity (AC) in the saliva was assessed by measuring free radical scav-
enging activity by 2,2′-azino-bis(3-ethylbenzothiazoline)-6-sulfonic acid diammonium
salt (ABTS) methods with appropriate modifications [10,13]. In brief, ABTS free radicals
(ABTS•+) having dark green color was generated by allowing the reaction equal volume
(each 2 mL) of the solutions of ABTS (7.4 mM) and potassium peroxodisulfate (2.6 mM) for
24 h. The reaction mixture was diluted to 100 mL with distilled water as a working solution
ABTS•+. Optical density (OD) of the working ABTS•+solution was approximately 0.5 to
0.6. Supernatant of saliva samples were used for both groups. Reactions were carried out
by mixing 450 µL of working solution of ABTS radical and 50 µL supernatant part of saliva
followed by incubating for 30 min in darkness. The changes in the green color of ABTS
free radicals scavenged by the antioxidants present in saliva fluid was measured for OD
using spectrophotometric methods (Agilent Technologies Deutschland GmbH, Waldbronn,
Germany) at 731 nm. Higher OD731 value represents lower level of TAC. Water soluble
vitamin C (Sigma-Aldrich) was used as a standard and AC was quantified as µg/mL
vitamin C equivalent level, representing AC with the help of standard curve and regression
equation (R2 = 0.931 and y = −0.0304x + 0.6134). The intra-assay coefficient of variation
was 0.73%.
2.6. Measurement of Oxidative Stress
We evaluated OS levels in saliva by measuring MDA content using a commercially
available MDA Assay Kit (Sigma-Aldrich, Lipid Peroxidation MDA Assay Kit (MAK085),
Darmstadt, Germany) [10]. In brief, a mixture of 100 µL saliva supernatant, 100 µL buffer
provided in the kit, and 600 µL thiobarbituric acid (TBA) solution were mixed thoroughly
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and incubated at 95 ◦C for 60 min. Of the reaction mixture, after cooling in ice, 150 µL
was transferred to a 96 well microplate in duplicates and absorbance was measured flu-
orometrically (Epoch Microplate, BioTek Instrument, Winooski, VT, USA) by measuring
fluorescence intensity (λex = 532/λem = 553). The MDA levels in the saliva were calculated
by the MDA standard provided in the kit with the help of standard curve and regression
equation (R2 = 0.9951 and y = 783.07x + 12.095). The intra-assay coefficient of variation was
6.91%.
2.7. Assessment of SM and LB in Saliva
Oral bacterial culture was assessed by a single investigator (MW) by saliva culture
and development of bacterial colony forming units (CFU) of two main bacteria, SM and
LB, using commercial kits Dentocult® LB (kit for LB), and Dentocult® SM Strip mutans (kit
for SM) (Orion Diagnostica Oy, Espoo, Finland) as described previously [10]. Women were
requested to chew a paraffin pellet to stimulate the secretion of saliva and promote transfer
of SM from tooth surfaces into the saliva. A round-tipped test strip supplied in the kits was
pressed against the saliva on the woman’s tongue. The strip was placed in the cap of the
vail containing culture broth and was recapped in the vail. The vial was loosely capped and
incubated at 37 ◦C and 5% CO2 for 48 h. Results were interpreted by scoring as Category
0, 1, 2, and 3 for 0, <105, 105–106, and >106 CFU/mL, respectively, by comparing to the
template reader provided in the kits. In case of LB culture, the test strip was thoroughly
made wet by saliva, fixed in the cap and fitted in the vials containing culture broth. It
was then incubated for 4 days at 37 ◦C and 5% CO2. Results were interpreted scoring as
Category 0, 1, 2, 3, and 4 for 0, 103, 104, 105, and 106 CFU/mL, respectively, by comparing
to the template reader provided in the kits. Results are expressed as the percentage of
women in each category based on the development of bacterial CFU. Both Dentocult®
SM and Dentocult® LB have been shown to have good reliability in determining different
categories of CFU counts and have a good correlation with standard culture techniques
using Agar plates [14,15].
2.8. Statistical Analysis
The sample size required for the detection of 15% difference in the OS level between
pregnant and non-pregnant women, with 80% power at an alpha of 0.05, was calculated
to be at least 38 individuals per group based on mean MDA level and standard deviation
(SD) reported in the saliva of 25 healthy female controls in a previous report [16] using an
online sample size calculator [17]. As our study on the pregnant women was longitudinal,
we recruited more participants to compensate for possible non-attendance or drop-outs
at follow-up visits, inadequate sample collection or analysis failure, to ensure that there
would be adequate number of samples/measurements for each stage of pregnancy.
Data analysis was performed using IBM SPSS Statistics for Windows, Version 25.0.
(IBM Corp, Armonk, NY, USA). Data are presented as mean (SD) as appropriate. Frequency
tables were made and comparison between the pregnant and non-pregnant groups was
carried out by conducting χ2 (chi-squared) test for categorical variables an independent
sample t-test for parametric continuous variables. Bonferroni correction was used when
multiple comparisons were performed. Comparisons between different stages of pregnancy
were made using analysis of variance (ANOVA) and Turkey’s posthoc test was used to
find out specific differences between multiple groups when the ANOVA was significant.
Associations of laboratory measured saliva parameters (i.e., NO, AC, MDA, and SM and
LB colony forming units) with pregnancy outcomes were analyzed using linear regression.
The strength of association between two continuous variables was assessed by Pearson’s
correlation coefficient. A p-value of <0.05 was considered statistically significant.
3. Results
Flow of study participants is shown in Figure 1. Data from a total of 96 pregnant and
50 non-pregnant women were included in the final analysis. The mean ages of the pregnant
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and non-pregnant groups were 30.81 ± 4.32 and 30.32 ± 6.09 years, respectively. The mean
gestational age at delivery was 39.51 ± 1.91 weeks with 80.2% (n = 77) women delivering
vaginally, whereas 19.8% (n = 19) had a caesarean section. Six women delivered preterm
(<37 weeks). Mean estimated blood loss during delivery was 498.06 ± 627.11 mL. Similarly,
53.3% of the neonates born were male and 46.7% females, and the mean weight and length
of the neonates were 3507.32 ± 631.67 gm and 48.87 ± 7.87 cm, respectively. The median
one- and five-minute Apgar scores of the neonates were 9 (range 1 to 10) and 10 (range 3 to
10), respectively.
Int. J. Environ. Res. Public Health 2021, 18, 9330 5 of 12 
 
 
and SM and LB colony forming units) with pregnancy outcomes were analyzed using lin-
ear regression. The strength of association between two continuous variables was assessed 
by Pearson’s correlation coefficient. A p-value of <0.05 was considered statistically signif-
icant. 
3. Results 
Flow of study participants is shown in Figure 1. Data from a total of 96 pregnant and 
50 non-pregnant women were included in the final analysis. The mean ages of the preg-
nant and non-pregnant groups were 30.81 ± 4.32 and 30.32 ± 6.09 years, respectively. The 
mean gestational age at delivery was 39.51 ± 1.91 weeks with 80.2% (n = 77) women eli -
ering vaginally, whereas 19.8% (n = 19) h d  caesarean section. Six women eli r  r -
term (<37 weeks). Mean estimated b od loss during delivery was 498.06 ± 627.11 mL. 
Similarly, 53.3% of the neo ates born were male and 46.7% females, and the mean weight 
and l ngth of the n onates were 3507.32 ± 631.67 gm and 48.87 ± 7.87 cm, resp ctively. Th  
medi  one- and fiv -minute Apgar scor s of the neonates were 9 (range 1 to 10) and 10 
(rang  3 to 10), respectively. 
 
Figure 1. Chart illustrating the flow of study participants. 
For the longitudinal evaluation, saliva samples were collected consecutively from 96 
healthy singleton pregnant women four times starting at 18–20 weeks to term pregnancy 
and from 50 healthy non-pregnant women. The samples were divided into four groups 
by gestational age: early second trimester (18–20 weeks, n = 96), late second trimester (24–
26 weeks, n = 65), early third trimester (30–32.0 weeks, n = 56), and late third trimester (36–
40 weeks, n = 31). The comparison group comprised of healthy non-pregnant women of 
reproductive age (n = 50) without history of any chronic illness or recent disease. 
3.1. Nitric Oxide (NO) Levels in Saliva 
Results for saliva nitrite concentrations of the subjects are shown in Table 1. The av-
erage saliva NO equivalent nitrite concentration in the 96 pregnant women measured in 
the early second trimester was 3.47 ± 2.48 µM, which was 30% higher compared to the 
group of non-pregnant women (2.67 ± 1.55 µM; p = 0.00029). Results showed that NO level 
continue to increase throughout the pregnancy, attaining peak levels in the end of third 
trimester (4.73 ± 2.87 µM). The levels of NO equivalent nitrite levels in late third trimester 
were 36% and 77% higher than in early second trimester of pregnancy (4.73 ± 2.87 µM) 
and in non-pregnant women (2.67 ± 1.55 µM), respectively. We found no statistically sig-
nificant association between salivary NO level measured with pregnancy outcomes, such 
as gestational age at delivery, birthweight, or Apgar score. 
Total participants
(N = 147)
one patient excluded 






















re 1. Chart illustrating the flow of study participants.
or the longitudinal evaluation, saliv samples were collected consecutively from 96
lt y singleton pregnant women four times s arting at 18–20 weeks to term pregnancy
fr 50 healthy non-pregnant women. The samples were divided into four groups
gestational age: early second trimester (18–20 weeks, n = 96), late second trimester
(24–26 weeks, n = 65), ea ly third rimester (30–32.0 weeks n = 56), and late third trimester
(36–40 weeks, n = 31). The comparis n gr up comprised of healthy no -pregnant women
of reproductive age (n = 50) without history of any chro ic illness or recent disease.
. . itric Oxide (NO) Levels in Saliva
esults for saliva n rite concentrations of the subject are shown in Tabl 1. The
average saliva NO equivalent nitrite concentration in the 96 pregnant women measured
in the early second trimester was 3.47 ± 2.48 µM, which was 30% higher compared to the
r f non-pregnant women (2.67 ± 1.55 µM; p = .00029). Results showed that NO level
c tinue to increase throughout the preg ancy, attaining peak levels in the end of third
tri ester (4.73 ± 2.87 µM). The levels of NO equivalent nitrite levels in late third trimester
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and in non-pregnant women (2.67 ± 1.55 µM), respectively. We found no statistically
significant association between salivary NO level measured with pregnancy outcomes,
such as gestational age at delivery, birthweight, or Apgar score.
3.2. Antioxidant capacity (AC) in Saliva
The results of average AC in the saliva of pregnant and non-pregnant women are
shown in Table 2. The AC is expressed as the measure of free radical scavenging capacity
of the saliva. Higher level of AC shows the saliva containing strong antioxidants. It can be
generalized that higher level of AC indicates low level of OS. The average saliva AC levels
of pregnant women (n = 96) measured at the early second trimester were 60.35 ± 14.33%
which is a 25% decrease in free radical scavenging capacity compared to non-pregnant
women (80.82± 11.60%; p < 0.00001). The AC levels did not change significantly throughout
pregnancy. AC levels in the saliva of pregnant women (n = 96) and non-pregnant women
(n = 50) were calculated as 16.26 µM and 11.89 µM vitamin C equivalent, respectively, with
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the regression equation: y = −0.0304x + 0.6134. No statistically significant association was
found between AC and pregnancy outcomes.
Table 1. Nitric oxide (NO) equivalent nitrite levels (µM) in the saliva of pregnant women at different
gestational ages and non-pregnant women.
Nitric Oxide (µM) NP Preg. I Preg. II Preg. III Preg. IV
Mean 2.67 3.47 3.67 4.56 4.73
SD 1.55 2.49 3.04 4.23 2.87
MAX 7.58 13.49 16.89 22.69 13.97
MIN 0.52 0.20 0.19 0.43 1.41
p-value vs. NP * 0.0004 0.0002 <0.0001 <0.0001
p-value vs. Preg. * 0.4279 0.0005 <0.0001
Results are expressed as mean ± SD. * Bonferroni correction and Turkey’s posthoc test was used when multiple
comparisons were performed. Preg. I: the early second trimester (18–20 weeks, n = 96), Preg. II: the late second
trimester (24–26 weeks, n = 65), Preg. III: early third trimester (30–32 weeks, n = 56) and Preg. IV: late third
trimester (36–40 weeks, n = 31), and NP: non-pregnant (n = 50).
Table 2. Antioxidant capacity (AC) in the saliva of pregnant women at different gestational ages and
non-pregnant women.
AC (%) NP Preg. I Preg. II Preg. III Preg. IV
Mean (%) 80.82 60.35 60.80 58.40 60.50
SD 11.60 14.33 15.18 15.18 17.58
p-value vs. NP * - <0.0001 <0.0001 <0.0001 <0.0001
p-value vs. Preg. I * - - 0.8745 0.1972 0.8745
The results are shown as the percentage mean and SD values for each group expressed as ABTS radical scavenging
capacity measured spectrophotometrically as optical density at 731 nm (OD731). * Bonferroni correction and
Turkey’s posthoc test was used when multiple comparisons were performed Preg. I: the early second trimester
(18–20 weeks, n = 96), Preg. II: the late second trimester (24–26 weeks, n = 65), Preg. III: early third trimester
(30–32 weeks, n = 56) and Preg. IV: late third trimester (36–40 weeks, n = 31), and NP: non-pregnant (n = 50).
3.3. Oxidative Stress (OS) Levels in Saliva
The results of MDA contents in the group of pregnant and non-pregnant women are
shown in Table 3. The OS levels are expressed as the MDA content present in the saliva. The
pregnant women had higher levels of MDA in their saliva compared to the non-pregnant
women reflecting higher level of OS in pregnant women. The average OS levels, ex-
pressed as MDA levels in the saliva of pregnant women in early second trimester gestation
(n = 96) and non-pregnant women (n = 50) were 0.93 nM and 0.85 nM; p = 0.008), respectively.
OS levels did not change significantly throughout second half of pregnancy. Association
between salivary OS level and pregnancy outcomes was not statistically significant.
Table 3. Oxidative stress level measured as MDA level in the saliva of pregnant women at different
gestational ages and non-pregnant women.
MDA (nM) NP Preg. I Preg. II Preg. III Preg. IV
Mean 0.85 0.93 0.95 0.97 0.96
SD 0.22 0.25 0.24 0.26 0.27
p-value vs. NP * - 0.0083 0.0018 0.0005 0.0055
p-value vs. Preg. I * - - 0.4901 0.2017 0.4673
The results are shown as mean (SD) of malondialdehyde (MDA) nM values for pregnant and non-pregnant
groups. * Bonferroni correction and Turkey’s posthoc test was used when multiple comparisons were performed.
Preg. I: the early second trimester (18–20 weeks, n = 96), Preg. II: the late second trimester (24–26 weeks, n = 65),
Preg. III: early third trimester (30–32.0 weeks, n = 56) and Preg. IV: late third trimester (36–40 weeks, n = 31), and
NP: non-pregnant (n = 50).
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3.4. Oral Bacterial Loads
3.4.1. Streptococcus mutans (SM)
The SM bacterial loads as compared between the groups of pregnant and non-pregnant
women are shown in Table 4. Almost 40% of pregnant women in their early and late third
trimester groups developed more than 105.CFU/mL SM colonies compared to 22% of
non-pregnant women. SM colonies were abundant and significantly higher in saliva of
pregnant compared to non-pregnant women (χ2 statistic = 5.375; p = 0.001). The colony
formation was significantly different at different stages of pregnancy (p = 0.0024) with the
highest proportion (38%) of women being colonized in the early third trimester. However,
the degree of SM colonization in the early second trimester was not significantly associated
with pregnancy outcomes.
Table 4. Streptococcus mutans (SM) counts in the saliva of pregnant women at different gestational
ages compared with non-pregnant women.
Group Category 0 (%) Category 1 (%) Category 2 (%) Category 3 (%)
Preg. I 11 (11.5) 25 (26.0) 35 (36.5) 25 (26.0)
Preg. II 6 (9.2) 22 (33.9) 24 (36.9) 13 (20.0)
Preg. III 6 (10.7) 13 (23.2) 22 (39.3) 15 (26.8)
Preg. IV 3 (10.0) 8 (26.7) 12 (40.0) 7 (23.3)
NP 20 (40.0) 12 (24.0) 11 (22.0) 7 (14.0)
Results are shown as number of subjects (%) in the categories 0 to 3. Preg. I: the early second trimester
(18–20weeks, n = 96), Preg. II: the late second trimester (24–26 weeks, n = 65), Preg. III: early third trimester
(30–32 weeks, n = 56), Preg. IV: late third trimester (36–40 weeks, n = 31), and NP: non-pregnant (n = 50).
Categories 0, 1, 2, and 3 represent the scoring for 0, <105, 105–106, and >106 CFU/mL SM bacterial colony forming
unit (CFU) counts, respectively.
3.4.2. Lactobacillus (LB)
The LB bacterial loads as compared between the groups of pregnant and non-pregnant
women are shown in the Table 5. The LB bacterial colonies formation were high and
significant during the different stages of pregnancy (p = 0.0027). Even though the LB
bacterial colonies were abundant in the saliva of pregnant women, it was not significantly
higher compared to non-pregnant women (χ2 statistic = 1.165; p = 0.489). Among pregnant
population almost 17% had developed 106 CFU/mL LB colonies in their late pregnancy
stage compared to 4% of non-pregnant women. Majority of non-pregnant showed 103 or
less CFU/mL LB colonies in their saliva. The degree of SM colonization in the early second
trimester was not significantly associated with pregnancy outcomes.
Table 5. Lactobacillus (LB) counts in the saliva of pregnant women at different gestational ages
compared with non-pregnant women.
Group Category 0 (%) Category 1 (%) Category 2 (%) Category 3 (%) Category 4 (%)
Preg. I 23 (24.0) 41 (42.7) 16 (16.7) 9 (9.4) 7 (7.3)
Preg. II 11 (16.9) 21 (32.3) 20 (30.8) 4 (6.2) 9 (13.8)
Preg. III 5 (8.9) 24 (42.9) 13 (23.2) 5 (8.9) 9 (16.1)
Preg. IV 2 (6.7) 16 (53.3) 4 (13.3) 3 (10.0) 5 (16.7)
NP 15 (30.0) 15 (30.0) 11 (22.0) 7 (14.0) 2 (4.0)
Results are shown as number of subjects (%) in categories 0 to 4. Preg. I: the early second trimester (18–20 weeks,
n = 96), Preg. II: the late second trimester (24–26 weeks, n = 65), Preg. III: early third trimester (30–32 weeks,
n = 56), Preg. IV: late third trimester (36–40 weeks, n = 31), and NP: non-pregnant (n = 50). Categories 0, 1,
2, 3, and 4 represent the scoring for 0, 103, 104, 105, and 106 CFU/mL LB bacterial colony forming unit (CFU)
counts, respectively.
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4. Discussion
In this study, we investigated the changes in NO production in saliva during pregnancy
and the levels of NO production were compared with non-pregnant healthy women
of reproductive age. We found a significantly higher NO production in the pregnant
women compared to the non-pregnant women and NO production also increased with
gestational age during normal pregnancy. It is, to our knowledge, the first report of the
NO measurements is saliva of pregnant women, however NO production in the blood
of pregnant women has been previously reported [6]. Based on some reports evaluating
blood samples, NO production is increased in the second trimester and peaks in the third
trimester [6,18,19]. In contrast to this, Hata et al. has reported that maternal circulating
nitrite level decrease with advancing gestation [20]. Brown et al. [21] and Smarason
et al. [22] found no changes in NO production during normal pregnancy compared to non-
pregnant women. These studies suggest that the status of NO production in women during
normal pregnancy is still controversial and needs further investigation. These discrepancies
may derive from methodological variations. Many of the previous studies have relied on
the measurement of NOx in the plasma; however, the plasma level is influenced by the
clearance, as well as the production of NO metabolites [23].
Saliva also has another very important function in maintaining oral health by reg-
ulating the microbial taxa in the oral cavity. Altered oral bacterial milieu and chemical
components of saliva have been associated with several diseases [1–3,8]. However, only
a few studies have investigated the effects of advancing gestational age on oral bacterial
load together with OS. In this study, we have measured NO levels in the saliva at different
gestational stages together with the OS and oral bacterial load of cries-related pathogens. It
is remarkable to find that pregnancy adversely affects oral health by promoting abnormal
bacterial growth and increasing NO and OS levels which are expressed in the saliva. It
could be that the NO production is a defense mechanism of the body against deteriorating
oral hygiene [24]. In 1999, Silva Mendez et al. reported that the nitrite present in saliva
could influence growth and survival of cariogenic bacteria [25].
Oral cavity harbors over 700 microbial taxa [26,27] and some microbial species are
shown to cause intrauterine infection without being present in the urogenital tract [28–30].
A study by Aagaard et al. has shown that microbes found in the term placenta are more
similar to those found in the oral cavity rather than vaginal microbes [31]. Pregnancy
is known to increase the risk for the development of dental caries compared to the non-
pregnant women [32]. SM and LB are considered as the causative bacteria for developing
dental caries [32,33]. Among these, SM is reported to be found only in human oral cav-
ity [34]. With this background, we measured SM and LB load in the saliva of pregnant
women at the different stages of physiological pregnancy and compared this with that of
the non-pregnant healthy women of similar age. Among healthy non-pregnant women, 20
out of 50 (40%) did not show the presence of SM in their saliva. Whereas in the pregnant
population, only 27 (10.5%) out of 248 total tested cases at various stages of pregnancies,
did not demonstrate the presence of SM in the saliva. These results clearly show that a
significantly higher number of pregnant women carry SM bacterial load in their oral cavity
(almost 89.5%) compared to non-pregnant women (60%). Our results partly support the
finding of previous studies reporting all pregnant women (100%) to have abundant SM
colonies in their saliva [32,35]. SM bacterial counts at different stages of pregnancy were
similar to each other. In general, both SM and LB bacterial loads were found higher in
pregnant women’s saliva compared to non-pregnant women, however, the difference was
statistically significant only for SM.
It is commonly accepted that OS has a part in the initiation and progression of most
oral diseases [36]. However, how the pregnancy associated changes in oral microbial
load (especially that of pathogenic bacteria) influence salivary OS and AC has not been
elucidated. We found lower levels of AC and higher levels of OS in pregnant women.
Nevertheless, the oral bacterial counts of SM and LB did not significantly correlate with AC
or OS neither in pregnant nor in non-pregnant groups. Therefore, it still remains unclear if
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it is the decreased levels of AC and increased levels of OS that creates a favorable condition
for oral bacterial growth in pregnant women or is it the increased bacterial growth that
leads to decreased AC and increased OS. Low levels of AC could be suggestive of increased
OS and increased potential for oxidative damage [37].
Antioxidants, such as vitamin C and vitamin E, are found in the saliva and play an
important role in the total antioxidative system of the oral cavity [38]. Salivary vitamin C
concentration has been reported to be 6 to 10 µg/mL by Hegde et al. [39]. In concordance
with this, in our study, mean AC levels in the saliva of pregnant and non-pregnant women
were 6.59 µg/mL and 7.17 µg/mL of vitamin C equivalent, respectively. We did not
measure vitamin C concentration directly in the saliva. However, on measuring ABTS
radical scavenging activity vitamin C equivalent of saliva provides a good estimate, as
the main AC effect is due to the vitamin C. Vitamin C helps to maintain the integrity
of teeth and overall oral health by contributing to non-enzymatic antioxidant defense.
Decreased serum and/or salivary vitamin C levels have been considered as one of the
factors associated with dental caries [39]. We measured a 34% lower value of AC in the
saliva of pregnant women compared to that of non-pregnant women. Therefore, decreased
AC may predispose women to poor oral health and increase the risk of dental caries
during pregnancy.
Excessive and uncontrolled production of ROS leads to OS, that in turn damages
cellular structures and alters functions of DNA, protein, and lipids. Antioxidants and
antioxidative system counteracts the ROS and/or prevent ROS formation [40–42]. Various
kinds of ROS are regularly generated during cellular metabolic processes, and a low to
moderate levels of ROS are physiological acting as signaling molecules [40,41]. MDA is
one of the cellular lipid metabolites generated by the ROS reaction, and therefore, OS levels
are generally expressed by the corresponding MDA metabolites concentration. Hence the
increased level of OS is indicated by higher MDA levels. In this study, OS was found to be
16% higher in the saliva of pregnant women compared to non-pregnant women (p = 0.023).
Our study has some limitations. We did not measure NO in the serum samples
parallelly with the saliva samples to avoid repeated invasive blood sampling from the
pregnant study participants. However, salivary and serum NO levels are shown to have
a positive correlation [43]. We compared healthy pregnancies from a general population
with a selected group of non-pregnant women which mainly consisted of women working
in the hospital and university and may possess better knowledge of oral health and oral
hygiene. Additionally, our study population mainly consisted of White European women,
and therefore the findings may not be directly applicable to other multi-ethnic populations.
The oxidative stress and antioxidative capacity may depend on life-style factors including
food intake and physical activity, which were not taken into account in this study. Similarly,
salivary components might have changed due to some variation in its collection timing.
Our study had adequate statistical power to demonstrate statistically significant differences
in salivary OS levels between pregnant and non-pregnant women as well as differences
between early second, late second and early third trimesters, among pregnant women.
However, the desired sample size was not reached for the late third trimester due to
increasing dropout of study participants with advancing gestational age. Although ABTS
free radical assay and MDA measurement are well documented reliable assays, we have not
performed other types of assays or measurements in serum or other body fluids from the
same women to evaluate OS. This may limit the generalizability of our findings. Our study
focused only on two caries-related bacteria, i.e., SM and LB, rather than investigating the
whole oral microbiome. Although these are the most important pathogens, the possible role
of other microbes in causing pregnancy associated changes in oral cavity cannot be ignored.
Furthermore, we did not perform any clinical oral examination before saliva sampling.
However, our study participants were healthy and none of them reported having any
significant medical illness or oral health problems.
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5. Conclusions
We report, for the first time, NO levels measured longitudinally in the saliva of
pregnant women and demonstrate that salivary NO increases with advancing gestational
age. OS and AC levels were stable during the second half of pregnancy. Normal pregnancy
was associated with increased levels of NO and OS, and decreased antioxidant capacity
compared with the non-pregnant state, and an abundant bacterial colonization of oral
cavity by both SM and LB was observed among healthy pregnant women during second
and third trimester of pregnancy indicating that pregnancy may have an adverse impact
on oral health. Therefore, it is important to provide essential awareness and provision of
optimal oral healthcare during pregnancy.
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